DAO and pancreatic adenocarcinoma: In the Figure 6C, we show a representative result in the pancreatic adenocarcinoma cell line IMIM-PC-2, and we can observe that none of the inhibitors had a statistically significant effect on CLytA-DAAO-induced cell death.